pyridoxal phosphate has been researched along with Kidney Diseases in 10 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conflicting data have been reported concerning the independent association between proteinuria and plasma total homocysteine (tHcy) levels, particularly among chronic renal disease (CRD) patients with a normal range serum creatinine." | 7.71 | Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. ( Bostom, AG; Jacques, PF; König, P; Kraatz, G; Kronenberg, F; Kuen, E; Lhotta, K; Mann, JF; Müller, GA; Neyer, U; Riegel, W; Riegler, P; Ritz, E; Schwenger, V; Selhub, J, 2001) |
| "Conflicting data have been reported concerning the independent association between proteinuria and plasma total homocysteine (tHcy) levels, particularly among chronic renal disease (CRD) patients with a normal range serum creatinine." | 3.71 | Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. ( Bostom, AG; Jacques, PF; König, P; Kraatz, G; Kronenberg, F; Kuen, E; Lhotta, K; Mann, JF; Müller, GA; Neyer, U; Riegel, W; Riegler, P; Ritz, E; Schwenger, V; Selhub, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarnak, MJ | 1 |
| Wang, SR | 1 |
| Beck, GJ | 1 |
| Kusek, JW | 1 |
| Selhub, J | 2 |
| Greene, T | 1 |
| Levey, AS | 1 |
| Dols, JL | 1 |
| van Zanten, AP | 1 |
| Lacour, B | 1 |
| Vassault, A | 1 |
| Degos, F | 1 |
| Bruneau, M | 1 |
| Kreis, H | 1 |
| Bailly, M | 1 |
| Ali, BH | 1 |
| Bashir, AA | 1 |
| Rofsky, NM | 1 |
| Earls, JP | 1 |
| Bostom, AG | 1 |
| Kronenberg, F | 1 |
| Jacques, PF | 1 |
| Kuen, E | 1 |
| Ritz, E | 1 |
| König, P | 1 |
| Kraatz, G | 1 |
| Lhotta, K | 1 |
| Mann, JF | 1 |
| Müller, GA | 1 |
| Neyer, U | 1 |
| Riegel, W | 1 |
| Schwenger, V | 1 |
| Riegler, P | 1 |
| Kojima, R | 1 |
| Ito, M | 1 |
| Suzuki, Y | 1 |
| Hafkenscheid, JC | 1 |
| Mascitelli-Coriandoli, E | 1 |
| Ieranò, A | 1 |
| Lissitzky, S | 1 |
| Laurent, B | 1 |
| Bernard, P | 1 |
| Fenasse, R | 1 |
1 review available for pyridoxal phosphate and Kidney Diseases
| Article | Year |
|---|---|
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clini | 1996 |
1 trial available for pyridoxal phosphate and Kidney Diseases
| Article | Year |
|---|---|
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cy | 2002 |
8 other studies available for pyridoxal phosphate and Kidney Diseases
| Article | Year |
|---|---|
Clinical implications of differences between two recommended procedures for determination of aspartate aminotransferase.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemistry, Clinical; Female; Heart Diseases; Huma | 1983 |
[In vitro supplementation of pyridoxal phosphate for the optimisation of the determination of the catalytic activity of alanine aminotransferase and aspartate aminotransferase in kidney transplant patients (author's transl)].
Topics: Adolescent; Adult; Aging; Alanine Transaminase; Aspartate Aminotransferases; Enzyme Activation; Fema | 1982 |
Comparative modulating effects of captopril, diltiazem, dietary calcium and pyridoxal-5'-phosphate on gentamicin-induced nephrotoxicity in the rat.
Topics: Animals; Body Weight; Calcium, Dietary; Captopril; Diltiazem; Female; Gentamicins; Glutathione; Inje | 1993 |
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
Topics: Adult; Aged; Chronic Disease; Creatinine; Female; Folic Acid; Glomerular Filtration Rate; Homocystei | 2001 |
Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (8): Protective effect of pyridoxal-5'-phosphate against tobramycin nephrotoxicity.
Topics: Animals; Anti-Bacterial Agents; Electrophoresis, Paper; Kidney; Kidney Diseases; Male; Membranes; Mi | 1990 |
Plasma pyridoxal-5'-phosphate concentration and its relation to apo-aminotransferase levels.
Topics: Apoenzymes; Apoproteins; Humans; Kidney Diseases; Pyridoxal Phosphate; Transaminases | 1987 |
[Compensatory hypertrophy of the remaining kidney in nephrectomized animals. IX. Behavior of pyridoxine and pyridoxal-5-phosphate].
Topics: Animals; Hypertrophy; Kidney; Kidney Diseases; Nephrectomy; Postoperative Complications; Pyridoxal P | 1968 |
[Experimental studies in a case of tyrosinosis. New pathogenic hypothesis].
Topics: Adult; Amino Acids; Animals; Blood Glucose; Carbon Dioxide; Chromatography; Depression, Chemical; Di | 1969 |